Hompes R, McDonald R, Buskens C, Lindsey I, Armitage N, Hill J, Scott A, Mortensen N J, Cunningham C
Department of Colorectal Surgery, Oxford University Hospitals, Oxford, UK.
Colorectal Dis. 2013;15(10):e576-81. doi: 10.1111/codi.12381.
Patients with unfavourable pathology after transanal endoscopic microsurgery (TEM) should be offered completion surgery (CS) if appropriate. The aim of this retrospective cohort study was to assess the short-term outcome and long-term oncological results of CS and identify factors compromising the quality of resection specimens.
Data were retrieved and analysed on patients who underwent CS from a comprehensive national TEM database (1992-2008) and the institutional prospective database from the Oxford University Hospitals (2008-2011).
There were 36 patients eligible for analysis. Postoperative complications occurred in 19 and were minor (grade I-II) in 13 and major (grade III-V) in six patients. The quality of the resected specimen was graded as good in 23 (64%), moderate in six (16.6%) and poor in seven (19.4%). Full-thickness excision by TEM (P = 0.03), an interval to CS greater than 7 weeks (P = 0.05) and distally located lesions (P = 0.04) were associated with increased risk for an inferior surgical specimen. Overall survival after CS was 91% at 1 year and 83% at 5 years. Patients with a 'good' TME specimen had significantly improved disease-free survival compared with patients with an 'inferior' specimen (100 vs 51%, P = 0.001).
Patients having full-thickness TEM excision, distally placed lesions and a long interval (> 7 weeks) to CS were likely to have an inferior TME specimen. The results confirm that CS after TEM does not negatively influence local recurrence and survival, but the reduced disease-free survival in patients with an inferior specimen is of concern.
经肛门内镜显微手术(TEM)后病理结果不理想的患者,若情况合适应接受根治性手术(CS)。本回顾性队列研究的目的是评估CS的短期疗效和长期肿瘤学结果,并确定影响切除标本质量的因素。
从一个全面的国家TEM数据库(1992 - 2008年)以及牛津大学医院的机构前瞻性数据库(2008 - 2011年)中检索并分析接受CS患者的数据。
有36例患者符合分析条件。19例发生术后并发症,其中13例为轻微(I - II级),6例为严重(III - V级)。切除标本质量评为良好的有23例(64%),中等的有6例(16.6%),差的有7例(19.4%)。TEM全层切除(P = 0.03)、至CS的间隔时间大于7周(P = 0.05)以及病变位于远端(P = 0.04)与手术标本质量较差的风险增加相关。CS后的1年总生存率为91%,5年为83%。与标本质量“差”的患者相比,标本质量“好”的患者无病生存率显著提高(100%对51%,P = 0.001)。
接受TEM全层切除、病变位于远端且至CS间隔时间长(> 7周)的患者,其TME标本质量可能较差。结果证实TEM后的CS不会对局部复发和生存产生负面影响,但标本质量差的患者无病生存率降低值得关注。